Original publikationer
2025. Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebocontrolled, primary prevention trial (PDF, 1,14 MB, nytt fönster).Anette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, Reinhard Berner, Kristina Casteels, Helena Elding Larsson, Florian Haupt, Angela Hommel, An Jacobs, Olga Kordonouri, M
https://www.gppad.lu.se/forskningsresultat-och-media/original-publikationer - 2026-05-05
